Literature DB >> 24864012

Immune complex formation and in situ B-cell clonal expansion in human cerebral cavernous malformations.

Changbin Shi1, Robert Shenkar1, Andrew Kinloch2, Scott G Henderson2, Mark Shaaya1, Anita S Chong3, Marcus R Clark2, Issam A Awad4.   

Abstract

Cerebral cavernous malformations (CCMs) represent clusters of dilated vascular channels, predisposing to hemorrhagic stroke and seizures. They are associated with defective blood brain barrier, hemorrhages of different ages and a robust inflammatory cell infiltrate. We report for the first time evidence of co-localized IgG and complement membrane attack complexes in CCM lesions. CD4(+) and CD8(+) T-cells are aggregated with CD20(+) B-cells. And IgG repertoire analyses demonstrate in situ B-cell clonal expansion and antigen-driven affinity maturation in CCMs. These results suggest an organ-intrinsic adaptive immune response in CCMs that should be further characterized as a potential therapeutic target.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody; Antigen; Cerebral cavernous malformations; Clonal expansion; IgG; Lymphocyte

Mesh:

Substances:

Year:  2014        PMID: 24864012     DOI: 10.1016/j.jneuroim.2014.04.016

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  13 in total

Review 1.  Cavernous angiomas: deconstructing a neurosurgical disease.

Authors:  Issam A Awad; Sean P Polster
Journal:  J Neurosurg       Date:  2019-07-01       Impact factor: 5.115

Review 2.  Genetics of cerebral cavernous malformations: current status and future prospects.

Authors:  H Choquet; L Pawlikowska; M T Lawton; H Kim
Journal:  J Neurosurg Sci       Date:  2015-04-22       Impact factor: 2.279

3.  B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models.

Authors:  Changbin Shi; Robert Shenkar; Hussein A Zeineddine; Romuald Girard; Maged D Fam; Cecilia Austin; Thomas Moore; Rhonda Lightle; Lingjiao Zhang; Meijing Wu; Ying Cao; Murat Gunel; Angeliki Louvi; Autumn Rorrer; Carol Gallione; Douglas A Marchuk; Issam A Awad
Journal:  J Neuroimmune Pharmacol       Date:  2016-04-16       Impact factor: 4.147

4.  RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations.

Authors:  Robert Shenkar; Changbin Shi; Cecilia Austin; Thomas Moore; Rhonda Lightle; Ying Cao; Lingjiao Zhang; Meijing Wu; Hussein A Zeineddine; Romuald Girard; David A McDonald; Autumn Rorrer; Carol Gallione; Peter Pytel; James K Liao; Douglas A Marchuk; Issam A Awad
Journal:  Stroke       Date:  2016-11-22       Impact factor: 7.914

5.  Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations.

Authors:  Romuald Girard; Hussein A Zeineddine; Maged D Fam; Anoop Mayampurath; Ying Cao; Changbin Shi; Robert Shenkar; Sean P Polster; Michael Jesselson; Ryan Duggan; Abdul-Ghani Mikati; Gregory Christoforidis; Jorge Andrade; Kevin J Whitehead; Dean Y Li; Issam A Awad
Journal:  Transl Stroke Res       Date:  2017-08-17       Impact factor: 6.829

6.  Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease.

Authors:  Romuald Girard; Omaditya Khanna; Robert Shenkar; Lingjiao Zhang; Meijing Wu; Michael Jesselson; Hussein A Zeineddine; Anupriya Gangal; Maged D Fam; Christopher C Gibson; Kevin J Whitehead; Dean Y Li; James K Liao; Changbin Shi; Issam A Awad
Journal:  Biomark Med       Date:  2016-02-09       Impact factor: 2.851

7.  Trial Readiness in Cavernous Angiomas With Symptomatic Hemorrhage (CASH).

Authors:  Sean P Polster; Ying Cao; Timothy Carroll; Kelly Flemming; Romuald Girard; Daniel Hanley; Nicholas Hobson; Helen Kim; James Koenig; Janne Koskimäki; Karen Lane; Jennifer J Majersik; Nichol McBee; Leslie Morrison; Robert Shenkar; Agnieszka Stadnik; Richard E Thompson; Joseph Zabramski; Hussein A Zeineddine; Issam A Awad
Journal:  Neurosurgery       Date:  2019-04-01       Impact factor: 4.654

8.  Polymorphisms in inflammatory and immune response genes associated with cerebral cavernous malformation type 1 severity.

Authors:  Hélène Choquet; Ludmila Pawlikowska; Jeffrey Nelson; Charles E McCulloch; Amy Akers; Beth Baca; Yasir Khan; Blaine Hart; Leslie Morrison; Helen Kim
Journal:  Cerebrovasc Dis       Date:  2014-12-03       Impact factor: 2.762

9.  Common transcriptome, plasma molecules, and imaging signatures in the aging brain and a Mendelian neurovascular disease, cerebral cavernous malformation.

Authors:  Janne Koskimäki; Sean P Polster; Yan Li; Sharbel Romanos; Abhinav Srinath; Dongdong Zhang; Julián Carrión-Penagos; Rhonda Lightle; Thomas Moore; Seán B Lyne; Agnieszka Stadnik; Kristina Piedad; Ying Cao; Robert Shenkar; Alexey V Dimov; Nick Hobson; Gregory A Christoforidis; Timothy Carroll; Romuald Girard; Issam A Awad
Journal:  Geroscience       Date:  2020-06-17       Impact factor: 7.713

10.  Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu.

Authors:  Dongdong Zhang; Andrew J Kinloch; Abhinav Srinath; Robert Shenkar; Romuald Girard; Rhonda Lightle; Thomas Moore; Janne Koskimäki; Azam Mohsin; Julián Carrión-Penagos; Sharbel Romanos; Le Shen; Marcus R Clark; Changbin Shi; Issam A Awad
Journal:  J Autoimmun       Date:  2020-04-30       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.